Johnston, Lloyd
Selecta Biosciences (United States)
3 papers on CoChat
Most cited papers
- Verified
Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles
Kishimoto, T. K., Ferrari, J. D., LaMothe, R. A., Kolte, P. N., Griset, A. P., O'Neil, C., Chan, V., Browning, E., Chalishazar, A., Kuhlman, W., et al. (2016) · Nature Nanotechnology
Immunotherapy and Immune ResponsesNanoparticle-Based Drug Delivery
Cited by 201
- Verified
Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia
Sands, E., Kivitz, A., DeHaan, W., Leung, S. S., Johnston, L., & Kishimoto, T. K. (2022) · Nature Communications
Gout, Hyperuricemia, Uric AcidDrug-Induced Adverse Reactions
Cited by 61
- Verified
ImmTOR nanoparticles enhance AAV transgene expression after initial and repeat dosing in a mouse model of methylmalonic acidemia
Ilyinskii, P. O., Michaud, A. M., Rizzo, G. L., Roy, C. J., Leung, S. S., Elkins, S. L., Capela, T., Chowdhury, A., Li, L., Chandler, R. J., et al. (2021) · Molecular Therapy - Methods & Clinical Development
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 39
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free